GB0813873D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0813873D0
GB0813873D0 GBGB0813873.7A GB0813873A GB0813873D0 GB 0813873 D0 GB0813873 D0 GB 0813873D0 GB 0813873 A GB0813873 A GB 0813873A GB 0813873 D0 GB0813873 D0 GB 0813873D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0813873.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of St Andrews
University of Dundee
Original Assignee
University of St Andrews
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of St Andrews, University of Dundee filed Critical University of St Andrews
Priority to GBGB0813873.7A priority Critical patent/GB0813873D0/en
Publication of GB0813873D0 publication Critical patent/GB0813873D0/en
Priority to PCT/GB2009/001884 priority patent/WO2010013011A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0813873.7A 2008-07-30 2008-07-30 Compounds Ceased GB0813873D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0813873.7A GB0813873D0 (en) 2008-07-30 2008-07-30 Compounds
PCT/GB2009/001884 WO2010013011A1 (en) 2008-07-30 2009-07-30 P53 tumor suppressor protein activating

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0813873.7A GB0813873D0 (en) 2008-07-30 2008-07-30 Compounds

Publications (1)

Publication Number Publication Date
GB0813873D0 true GB0813873D0 (en) 2008-09-03

Family

ID=39747130

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0813873.7A Ceased GB0813873D0 (en) 2008-07-30 2008-07-30 Compounds

Country Status (2)

Country Link
GB (1) GB0813873D0 (en)
WO (1) WO2010013011A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR101623985B1 (en) 2007-03-28 2016-05-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Stitched polypeptides
JP2013535514A (en) 2010-08-13 2013-09-12 エイルロン セラピューティクス，インコーポレイテッド Peptidomimetic macrocycle
JP6342808B2 (en) 2011-10-18 2018-06-13 エイルロン セラピューティクス，インコーポレイテッド Peptidomimetic macrocycle
AU2013221433B2 (en) 2012-02-15 2018-01-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112014020103A2 (en) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. peptidomimetic macrocycles
BR112015009470A2 (en) 2012-11-01 2019-12-17 Aileron Therapeutics Inc disubstituted amino acids and their methods of preparation and use
CN105531268B (en) 2013-05-07 2017-09-12 加拉佩格斯股份有限公司 Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis
ES2691944T3 (en) 2013-08-08 2018-11-29 Galapagos Nv Tieno [2,3-c] pyrans as CFTR modulators
CN107106642B (en) 2014-09-24 2021-02-26 艾瑞朗医疗公司 Peptidomimetic macrocycles and formulations thereof
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
CA2979847A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1
US11091522B2 (en) 2018-07-23 2021-08-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921765B2 (en) * 2000-09-20 2005-07-26 Aprea Ab 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
AR038957A1 (en) * 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
PT1458386E (en) * 2001-12-27 2007-06-04 Ortho Mcneil Pharm Inc Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder

Also Published As

Publication number Publication date
WO2010013011A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0812641D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0813873D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0812622D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0802586D0 (en) Compounds
GB0802231D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds
GB0802191D0 (en) Compounds
GB0801596D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0803493D0 (en) Compounds
GB0801219D0 (en) Compounds
GB0800961D0 (en) Compounds
GB0812646D0 (en) Compounds
GB0803495D0 (en) Compounds
GB0803496D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)